Disease Severity and Delays in Treatment in CSU

Author(s):

Key Takeaways

UAS7 and UCT are essential tools for assessing CSU severity and control, aiding in treatment decisions.
Delayed diagnosis of CSU is frequent, often due to symptom overlap and lack of awareness.
Prolonged suffering and increased healthcare costs are significant implications of delayed CSU diagnosis.

Panelists discuss how disease severity in chronic spontaneous urticaria (CSU) is assessed using tools such as the Urticaria Activity Score over 7 days (UAS7) and the Urticaria Control Test (UCT), while also addressing the frequency of delayed diagnoses and the significant implications for condition management and patient quality of life.

EP: 1.Bringing CSU Back Under The House of Dermatology

EP: 2.Understanding the Chronicity of CSU

EP: 3.The Psychosocial Impact of CSU

EP: 4.The Pathogenesis of CSU

EP: 5.Tips on Diagnosing CSU

EP: 6.Less Is More: Diagnostic Testing for CSU

Now Viewing

EP: 7.Disease Severity and Delays in Treatment in CSU

EP: 8.The Role of Dermatologists in Treating CSU

EP: 9.Treatment Approaches and the Limitations of Antihistamines for CSU

EP: 10.Steroids and Immunosuppressive Agents for CSU

EP: 11.Novel Therapeutics in Development for CSU

EP: 12.The Role of BTK Inhibition in CSU

EP: 13.The Importance of Patient Education and Shared Decision-Making in CSU

EP: 14.The Role of BTK Inhibitors in the Evolving CSU Treatment Landscape

EP: 15.Unmet Needs in CSU Management

EP: 16.Key Takeaways and Future Directions in CSU Care

Video content above is prompted by the following:

How is disease severity assessed?
1. UAS7
2. UCT
How frequently do patients receive a delayed diagnosis? What are the implications associated with this delay?